All Stories

  1. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy
  2. Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
  3. Comparison of costs of treatment of Degludec/Liraglutide association versus basal bolus therapy
  4. The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
  5. Adherence in ulcerative colitis: an overview
  6. Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy
  7. Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
  8. Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
  9. Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer